Detalhe da pesquisa
1.
A Phase 1 Study of a CDH6-Targeting Antibody-Drug Conjugate in Patients with Advanced Solid Tumors with Evaluation of Inflammatory and Neurological Adverse Events.
Oncol Res Treat
; 44(10): 547-556, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34515215